Skip to main navigation Skip to search Skip to main content

Weekly: Y-mAbs Therapeutics (YMAB: $5.62) tumbles 10%; -63c [10.1%]

Press/Media: Research

PeriodAug 7 2023

Media coverage

1

Media coverage